NDC 0338-9665 – Doxil

Doxorubicin Hydrochloride 2 mg/mL · Injection, Suspension, Liposomal · Intravenous

Human Prescription Drug

Product NDC0338-9665

Product details

Brand name
Doxil
Generic name
Doxorubicin hydrochloride
Labeler
Baxter Healthcare Corporation
Dosage form
Injection, Suspension, Liposomal
Route
Intravenous
Marketing category
NDA · NDA050718
Marketed since
August 26, 2024
Listing expires
December 31, 2027
Pharmacologic class
Anthracycline Topoisomerase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Doxil →

Package NDC codes (1)

Package NDCDescriptionSince
0338-9665-011 VIAL, SINGLE-DOSE in 1 CARTON (0338-9665-01) / 25 mL in 1 VIAL, SINGLE-DOSEAug 26, 2024

Other Doxil products